Book contents
- The Frith Prescribing Guidelines for People with Intellectual Disability
- Reviews
- The Frith Prescribing Guidelines for People with Intellectual Disability
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Acknowledgements
- Chapter 1 Intellectual Disability
- Chapter 2 Prescribing Practice
- Chapter 3 Physical Health Monitoring
- Chapter 4 Mental Health Conditions in People with Intellectual Disability
- Chapter 5 Trauma in People with Intellectual Disability
- Chapter 6 Anxiety Disorders
- Chapter 7 Depression
- Chapter 8 Bipolar Disorders
- Chapter 9 Schizophrenia
- Chapter 10 Aggression and Self-Injurious Behaviour
- Chapter 11 Personality Disorders
- Chapter 12 Sexual Offences and Paraphilias
- Chapter 13 Substance Use Disorders
- Chapter 14 Attention Deficit Hyperactivity Disorder
- Chapter 15 Autism
- Chapter 16 Sleep Disorders
- Chapter 17 Epilepsy
- Chapter 18 Dementia
- Chapter 19 Eating and Drinking Difficulties
- Chapter 20 Children and Adolescents
- Chapter 21 Prescribing for Health Issues in Women with Intellectual Disability
- Chapter 22 Older People
- Index
- References
Chapter 3 - Physical Health Monitoring
Published online by Cambridge University Press: 07 November 2024
Book contents
- The Frith Prescribing Guidelines for People with Intellectual Disability
- Reviews
- The Frith Prescribing Guidelines for People with Intellectual Disability
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Acknowledgements
- Chapter 1 Intellectual Disability
- Chapter 2 Prescribing Practice
- Chapter 3 Physical Health Monitoring
- Chapter 4 Mental Health Conditions in People with Intellectual Disability
- Chapter 5 Trauma in People with Intellectual Disability
- Chapter 6 Anxiety Disorders
- Chapter 7 Depression
- Chapter 8 Bipolar Disorders
- Chapter 9 Schizophrenia
- Chapter 10 Aggression and Self-Injurious Behaviour
- Chapter 11 Personality Disorders
- Chapter 12 Sexual Offences and Paraphilias
- Chapter 13 Substance Use Disorders
- Chapter 14 Attention Deficit Hyperactivity Disorder
- Chapter 15 Autism
- Chapter 16 Sleep Disorders
- Chapter 17 Epilepsy
- Chapter 18 Dementia
- Chapter 19 Eating and Drinking Difficulties
- Chapter 20 Children and Adolescents
- Chapter 21 Prescribing for Health Issues in Women with Intellectual Disability
- Chapter 22 Older People
- Index
- References
Summary
People with intellectual disability have a higher rate of mortality and morbidity. Prescribing medication requires regular physical monitoring to ensure that the person with intellectual disability is not put at additional risk of health problems. The chapter provides details of necessary testing.
- Type
- Chapter
- Information
- Publisher: Cambridge University PressPrint publication year: 2024
References
Alexander, R. T., Shankar, R., Cooper, S. A., et al. (2017). Challenges and pitfalls of antipsychotic prescribing in people with learning disability. British Journal of General Practice, 67(661), 372–3.CrossRefGoogle ScholarPubMed
Amiola, A., Temple, P., Dickerson, H., et al. (2022). A pilot project to introduce the Compassionate Approach to Living Mindfully for Prevention of Disease (Calmpod) in weight management in a forensic intellectual disability unit. BJPsych Open, 8(S1), S82–S83.CrossRefGoogle Scholar
Biswas, A., Shaherbano, S., & Hiremath, A. (2024). Obesity in people with intellectual disabilities. University of Herfordshire. www.intellectualdisability.info/physical-health/obesity-in-people-with-intellectual-disabilities.Google Scholar
Carrière, K., Khoury, B., Günak, M. M., & Knäuper, B. (2018) Mindfulness-based interventions for weight loss: A systematic review and meta-analysis. Obesity Reviews, Feb; 19(2), 164–77. https://doi.org/10.1111/obr.12623. Epub 2017 Oct 27. PMID: 29076610.CrossRefGoogle ScholarPubMed
Crowell, M. D. (2004). Role of serotonin in the pathophysiology of the irritable bowel syndrome. British Journal of Pharmacology, 141(8), 1285–93. https://doi.org/10.1038/sj.bjp.0705762.CrossRefGoogle ScholarPubMed
Holt, R. I. and Peveler, R. C. (2009). Obesity, serious mental illness and antipsychotic drugs. Diabetes, Obesity and Metabolism, 11(7), 665–79.CrossRefGoogle ScholarPubMed
Holt, R. I. (2019). The management of obesity in people with severe mental illness: an unresolved conundrum. Psychotherapy and Psychosomatics, 88(6), 327–32.CrossRefGoogle ScholarPubMed
Hertfordshire Partnership University NHS Foundation Trust (2020). Physical Health Policy Procedure for the Assessment, Examination and Physical Wellbeing Support of Service Users. www.hpft.nhs.uk/media/1842/item-13a-physical-health-strategy-final-board-paper.pdf.Google Scholar
Kennedy, N., Kennedy, J., Kerr, M., Dredge, S., & Brophy, S. (2022). Health checks for adults with intellectual disability and association with survival rates: A linked electronic records matched cohort study in Wales, UK. BMJ Open, 12(4), p.e049441. https://doi.org/10.1136/bmjopen-2021-049441.CrossRefGoogle ScholarPubMed
Kouidrat, Y, Amad, A, Stubbs, B, Moore, S, & Gaughran, F. (2017) Surgical management of obesity among people with schizophrenia and bipolar disorder: A systematic review of outcomes and recommendations for future research. Obesity Surgery, Jul; 27(7), 1889–95.CrossRefGoogle ScholarPubMed
Lean, M. E., Leslie, W. S., Barnes, A. C., et al. (2019). Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. The Lancet Diabetes & Endocrinology, 7(5), 344–55.CrossRefGoogle ScholarPubMed
Learning Disability Mortality Review (LeDeR) Programme Annual Report. (2020). www.bristol.ac.uk/media-library/sites/sps/leder/LeDeR_2019_annual_report_FINAL2.pdf.Google Scholar
Learning Disability Mortality Review (LeDeR) Programme: Action from Learning NHS England and NHS Improvement. (n.d.). www.england.nhs.uk/wp-content/uploads/2019/05/action-from-learning.pdf.Google Scholar
Leth-Møller, K. B., Hansen, A. H., Torstensson, M., et al. (2016). Antidepressants and the risk of hyponatremia: A Danish register-based population study. BMJ Open, 6(5). https://doi.org/10.1136/bmjopen-2016-011200.CrossRefGoogle ScholarPubMed
Liao, P., Vajdic, C., Trollor, J., & Reppermund, S. (2021). Prevalence and incidence of physical health conditions in people with intellectual disability – a systematic review. PLOS ONE, 16(8), p.e0256294. https://doi.org/10.1371/journal.pone.0256294.CrossRefGoogle ScholarPubMed
Mathew, R., Attarha, B.O., Kallumkal, G., et al. (2021). A primary care approach to constipation in adults with intellectual and developmental disabilities. Advances in Medicine, 2021, p.3248052. https://doi.org/10.1155/2021/3248052.CrossRefGoogle ScholarPubMed
Melville, C. A., Cooper, S. A., Morrison, J., et al. (2008). The prevalence and determinants of obesity in adults with intellectual disabilities. Journal of Applied Research in Intellectual Disabilities, 21(5), 425--37.CrossRefGoogle Scholar
Morad, M., Nelson, N. P., Merrick, J., Davidson, P. W., & Carmeli, E. (2007). Prevalence and risk factors of constipation in adults with intellectual disability in residential care centres in Israel. Research in Developmental Disabilities, 28(6), 580–6. https://doi.org/10.1016/j.ridd.2006.08.002.CrossRefGoogle ScholarPubMed
MyPsych, NHS Greater Glasgow and Clyde web site (n.d.). Clozapine and Constipation. https://rightdecisions.scot.nhs.uk/mypsych-app/working-in-greater-glasgow-clyde/medicines-companion/clozapine/clozapine-and-constipation/.Google Scholar
National Institute of Health and Care Excellence (NICE) (2014). Psychosis and schizophrenia in adults: prevention and management: Guideline CG178. www.nice.org.uk/guidance/cg178.Google Scholar
National Institute of Health and Care Excellence (NICE) (2014). Obesity: Identification, Assessment and Management. Clinical Guideline CG 189, updated September 2022. www.nice.org.uk/guidance/cg189.Google Scholar
National Institute for Health and Care Excellence (NICE) (2015). Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges, NG 11. www.nice.org.uk/guidance/ng11.Google Scholar
National Institute for Health and Care Excellence (NICE) (2016). Mental health problems in people with learning disabilities: prevention, assessment and management NG54. www.nice.org.uk/guidance/ng54.Google Scholar
National Institute for Health and Care Excellence (NICE) (2017). Obese, Overweight with risk factors: Liraglutide (Saxenda) Evidence Summary. www.nice.org.uk/guidance/ta875.Google Scholar
National Institute for Health and Care Excellence (NICE) (2018). Clinical Guideline 87; www.nice.org.uk/guidance/ng87/chapter/Recommendations#maintenance-and-monitoring.Google Scholar
National Institute for Health and Care Excellence (NICE) (2020). Liraglutide for managing overweight and obesity, Technology appraisal guidance [TA664.] Published 9 December 2020. www.nice.org.uk/guidance/ta664.Google Scholar
National Institute for Health and Care Excellence (NICE) (2012). Semaglutide for obesity, published February 2022. www.nice.org.uk/news/article/nice-recommends-new-drug-for-people-living-with-obesity.Google Scholar
NHS England (n.d.). Annual health checks. www.england.nhs.uk/learning-disabilities/improving-health/annual-health-checks/.Google Scholar
Olianas, M.C., Dedoni, S., Ambu, R., & Onali, P. (2009). Agonist activity of N-desmethylclozapine at δ-opioid receptors of human frontal cortex. European Journal of Pharmacology, 607(1–3), 96–101. https://doi.org/10.1016/j.ejphar.2009.02.025.CrossRefGoogle ScholarPubMed
Prajapathi, A. R. (2014). Role of metformin in the management of antipsychotic-induced weight gain. Progress in Neurology and Psychiatry, Nov–Dec, 33–8. https://wchh.onlinelibrary.wiley.com/doi/pdf/10.1002/pnp.358.Google Scholar
Rajan, L., & Clarke, I. (2013). Audit of combination and high-dose antipsychotic treatment in the community. The Psychiatrist, 37(9), 302--7. https://doi.org/10.1192/pb.bp.112.039750.CrossRefGoogle Scholar
Robertson, J., Hatton, C., Emerson, E., & Baines, S. (2014). The impact of health checks for people with intellectual disabilities: An updated systematic review of evidence. Research in Developmental Disabilities, 35(10), 2450–62. https://doi.org/10.1016/j.ridd.2014.06.007.CrossRefGoogle ScholarPubMed
Rowland, J. P., Rigby, J., Harper, A. C., & Rowland, R. (2007). Cardiovascular monitoring with acetylcholinesterase inhibitors: A clinical protocol. Advances in Psychiatric Treatment, 13(3), 178–84. https://doi.org/10.1192/apt.bp.106.002725.CrossRefGoogle Scholar
Royal College of Psychiatrists (2016) Psychotropic drug prescribing for people with intellectual disability, mental health problems and/or behaviours that challenge: practice guidelines. www.rcpsych.ac.uk/docs/default-source/members/faculties/intellectual-disability/id-faculty-report-id-09.pdf?sfvrsn=55b66f2c_6.Google Scholar
Royal College of Psychiatrists (2014; January 2023 revision) Report CR190: The risks and benefits of high-dose antipsychotic medication. www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/college-reports/college-report-cr190.pdf?sfvrsn=54f5d9a2_11.Google Scholar
Russell, R., Chester, V., Watson, J., et al. (2018). The prevalence of overweight and obesity levels among forensic inpatients with learning disability. British Journal of Learning Disabilities, 46(2), 101–108.CrossRefGoogle Scholar
Samele, C., Seymour, L., Morris, B., et al. (2006) A formal investigation into health inequalities experienced by people with learning difficulties and people with mental health problems – Area Studies Report. Report to the Disability Rights Commission (DRC). The Sainsbury Centre for Mental Health.Google Scholar
Shirazi, A., Stubbs, B., Gomez, L., et al. (2016). Prevalence and predictors of clozapine-associated constipation: A systematic review and meta-analysis. International Journal of Molecular Sciences, 17(6), 863. https://doi.org/10.3390/ijms17060863.CrossRefGoogle ScholarPubMed
SPS – Specialist Pharmacy Service (2022). Managing constipation in people taking clozapine. www.sps.nhs.uk/articles/managing-constipation-in-people-taking-clozapine/.Google Scholar
South West London & St George’s Mental Health NHS Trust guideline. Guidance for recommended on going physical monitoring of psychotropic medication in primary care. https://swlstg.nhs.uk/download.cfm?ver=1101.Google Scholar
Talley, N. J., Jones, M., Nuyts, G., & Dubois, D. (2003). Risk factors for chronic constipation based on a general practice sample. The American Journal of Gastroenterology, 98(5), 1107–11. https://doi.org/10.1111/j.1572-0241.2003.07465.x.CrossRefGoogle ScholarPubMed
Taylor, D. M., Gaughran, F. & Pillinger, T. (2020) (Eds.), The Maudsley Practice Guidelines for physical health conditions in psychiatry. Wiley Blackwell.Google Scholar
Taylor, D. M., Barnes, T. R. and Young, A. H., et al. (2021) The Maudsley Prescribing Guidelines in Psychiatry. Wiley Blackwell.CrossRefGoogle Scholar
Mencap (2018). Treat me well: Reasonable adjustments for people with a learning disability in hospital. www.mencap.org.uk/sites/default/files/2018-06/Treat%20me%20well%20top%2010%20reasonable%20adjustments.pdf.Google Scholar
Tyrer, P., Cooper, S.-A., & Hassiotis, A. (2014). Drug treatments in people with intellectual disability and challenging behaviour. British Medical Journal, 349(jul04 1), g4323–g4323. https://doi.org/10.1136/bmj.g4323.CrossRefGoogle ScholarPubMed
World Health Organization. Health topics: obesity. www.who.int/health-topics/obesity/#tab=tab_1.Google Scholar